发明名称 DERIVATIVE OF SPHINGOSINE
摘要 PROBLEM TO BE SOLVED: To provide a new compound having a sphingomyelinase antagonism. SOLUTION: This compound is a derivative of sphingosine or its pharmaceutically permissible salt expressed by general formula I [R1 is H, a 2-20C alkanoyl, benzoyl or the like, R2 is H, a 1-8C alkyl, -(CH2)nR5 (R5 is hydroxyl, an amino, a pyridyl, a pyrazyl, a morpholinyl, a thiazolyl, a tetrazolyl or the like, n is an integer of 0-5) or SOmR6 (R6 is phenyl or a substituted phenyl substituted with a halogen, a 1-5C alkyl, hydroxyl, an amino, an ureide group or the like, m is 0, 1 or 2.), Z is NR7 (R7 is H, hydroxyl or a 1-5C alkyl), Y is oxygen or NR8 (R8 is H or hydroxyl or a 1-5C alkyl), W is oxygen or sulfur, k is an integer of 1-20].
申请公布号 JP2001213858(A) 申请公布日期 2001.08.07
申请号 JP20000355117 申请日期 2000.11.22
申请人 SAGAMI CHEM RES CENTER;TAISHO PHARMACEUT CO LTD 发明人 KOBORI TAKEO;SUGIMOTO KIKUO;AIDA KENICHI;TAGUCHI MINORU
分类号 C07D295/12;A61K31/17;A61K31/192;A61K31/235;A61K31/27;A61K31/275;A61K31/41;A61K31/416;A61K31/4164;A61K31/426;A61K31/433;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/47;A61K31/4965;A61K31/5375;A61P3/04;A61P3/10;A61P9/10;A61P13/12;A61P25/14;A61P25/16;A61P25/28;A61P29/00;A61P35/00;A61P37/00;A61P43/00;C07C271/12;C07C271/16;C07C271/18;C07C271/20;C07C271/22;C07C271/28;C07C275/20;C07C275/42;C07C311/53;C07C323/43;C07D213/36;C07D213/75;C07D215/38;C07D231/56;C07D233/64;C07D241/20;C07D257/04;C07D277/20;C07D277/48;C07D285/135 主分类号 C07D295/12
代理机构 代理人
主权项
地址